U.S. Paper and Forestry Products Stock News

NYSE:SCHW
NYSE:SCHWCapital Markets

3 Stocks Tied To Higher Cash Yields Including Charles Schwab Stock

Fed officials are keeping short-term rates high and signaling they could stay there, which keeps cash, T‑bills, and short‑duration bond yields in sharp focus for every investor trying to park money without going all in on long-term risk. That backdrop creates real FOMO around which providers may benefit from persistent demand for parking cash. This article walks through three stocks exposed to that rate story and explains why the latest Fed messaging matters for each one. The three stocks in...
NasdaqGS:GLPI
NasdaqGS:GLPISpecialized REITs

Gaming And Leisure Properties (GLPI) Stock Could Be Worth A Closer Look

Gaming and Leisure Properties has seen a mixed share price record, with the stock giving investors a positive 15.8% total return over the past 5 years but slipping over the shorter term. That combination highlights a straightforward question for you as a shareholder or prospective buyer: whether today's valuation can be explained by the earnings the business produces. The 15.8% gain over 5 years shows that long term holders have seen progress, which now raises the issue of whether the...
NYSE:WES
NYSE:WESOil and Gas

Western Midstream Partners (WES) Could Be 5% Undervalued If Growth Projects Deliver

Western Midstream Partners (WES) has drawn attention after a recent move in the units, with the price finishing at US$47.29. Investors are weighing this level against performance over the past month and the past 3 months. Short term momentum for Western Midstream Partners has cooled, with the share price down 3.6% over the past week and 2.2% over the past month. However, the 19.1% year to date share price return and very strong multi year total shareholder returns suggest longer term buyers...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

Why CRISPR Therapeutics (CRSP) Is Back In The Spotlight

CRISPR Therapeutics (NasdaqGM:CRSP) heads into the Morgan Stanley 24th Annual Global Healthcare Conference on 14 September 2026, giving investors fresh context for a gene editing pipeline that spans hemoglobinopathies, CAR T therapies and type 1 diabetes. Over the past week, CRISPR Therapeutics has seen a 7-day share price return of 9.36%, even though the 1-month share price return is down 4.94%. The 1-year total shareholder return has declined 9.24%, while the 3-year total shareholder return...
NYSE:SIG
NYSE:SIGSpecialty Retail

Why Signet Jewelers (SIG) Is Back In The Spotlight

Signet Jewelers (SIG) is back in focus after reporting a return to profitability in its second quarter, reaffirming sales guidance and pairing those updates with a renewed credit partnership and ongoing capital returns. That return to profit has arrived alongside a strong rebound in momentum, with a 30-day share price return of 23.4% and a 90-day gain of 15.7% helping lift Signet Jewelers to US$100.38. The 3-year total shareholder return of 42.8% tells a longer story of improving sentiment...
NYSE:ECL
NYSE:ECLChemicals

Ecolab (ECL) On One Ecolab Narrative As Valuation Debate Sharpens

Ecolab (ECL) is set to address investors at Morgan Stanley's 14th Annual Laguna Conference on 15 September 2026, where it will offer fresh commentary on its water, hygiene and infection prevention operations. Ecolab shares trade at US$269.46 after easing 4.3% over the past month and 2.4% over the last week, while a 1 year total shareholder return of 2.6% contrasts with a much stronger 3 year total shareholder return of 61.6%. This suggests earlier momentum has cooled ahead of the upcoming...
NYSE:ABCB
NYSE:ABCBBanks

Ameris Bancorp (ABCB) Could Be 11% Below Fair Value As Dividend Lands

Ameris Bancorp (ABCB) has declared a quarterly dividend of $0.20 per share, payable on October 5, 2026, to shareholders of record as of September 30, 2026. Ameris Bancorp’s latest dividend decision comes after a steady run this year, with a year-to-date share price return of 12.87%. This is despite a 3.13% decline over the past 30 days and a 4.42% decline over the past 90 days. Compare Ameris Bancorp’s income focus with other hand-picked banks and financials that pair steady payouts with...
NYSE:VIPS
NYSE:VIPSMultiline Retail

Is Vipshop Holdings (VIPS) A Bargain As Its Share Price Slide Tests Fair Value?

Vipshop Holdings (NYSE:VIPS) sits in focus after a recent share price slide, with the stock down over the past month and past 3 months, inviting closer scrutiny from value oriented investors. Over the past year, momentum in Vipshop Holdings has clearly cooled, with the share price down 30.49% year to date and the 1-year total shareholder return also declining 30.34%. However, the 5-year total shareholder return of 13.60% points to a far more resilient long run picture. Scan beyond Vipshop...
NYSE:AEE
NYSE:AEEIntegrated Utilities

How Investors Are Reacting To Ameren (AEE) $900 Million Debt Offering

Ameren has issued callable, subordinated fixed to floating rate notes due March 15, 2057, raising US$900 million in unsecured corporate debt. The company has also presented at the Barclays 40th Annual Energy-Power Conference in New York. This combination of long dated, junior funding and public engagement with institutional investors indicates active balance sheet planning around future infrastructure and grid investment needs. We will examine how Ameren's investment narrative around long...
NasdaqGS:PTEN
NasdaqGS:PTENEnergy Services

Patterson-UTI Energy (PTEN) Draws Fresh Valuation Focus, Is It Still Below Fair Value?

Patterson-UTI Energy (PTEN) has come into focus after its shares closed at US$11.78, with a reported 129.8% total return over the past year despite the company posting a loss. In the short term, the share price has pulled back, with a 7 day share price return of down 8.33% and a 1 month share price return of down 4.54%. However, Patterson-UTI Energy still shows strong momentum, with an 82.07% year to date share price return and a 129.77% 1 year total shareholder return. Scan beyond...
NYSE:ELV
NYSE:ELVHealthcare

Is Elevance Health (ELV) Fairly Valued On Its Conference Outlook Reassurance?

Elevance Health (ELV) used its appearance at the Wells Fargo 21st Annual Healthcare Conference on 10 September 2026 to reinforce its earnings outlook and cost discipline, keeping the recent valuation conversation very much alive. Recent trading has been mildly soft, with the share price down 0.8% on the day and 1.9% over the past week. Even so, Elevance Health still carries a 16.0% year to date share price return and a 33.6% 1 year total shareholder return, indicating that momentum has cooled...
NasdaqGM:SMMT
NasdaqGM:SMMTBiotechs

Did Updated Survival Data Just Shift Summit Therapeutics (SMMT) Investment Narrative?

Summit Therapeutics reported updated Phase III HARMONi data for ivonescimab plus chemotherapy in EGFR mutated non squamous NSCLC, with overall survival and safety results remaining consistent and favorable across Asian and western patients, and forming the core of its ongoing U.S. BLA review. The repeated overall survival hazard ratio of 0.76 across the global population and western subgroup highlights how ivonescimab’s effect looks regionally aligned. This matters for Summit Therapeutics as...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

Enphase Energy (ENPH) Could Be 35% Undervalued After Its AI Data Center Power Push

Enphase Energy (ENPH) just pushed deeper into AI power infrastructure by starting US production of power modules for its IQ Solid-State Transformer racks, which are aimed at 800 VDC AI data centers. That push into AI infrastructure comes after a tough stretch for Enphase Energy’s shareholders, with the share price falling about 34% over the past 90 days and roughly 10% over the past month, even as the year-to-date share price return is slightly positive. The 5-year total shareholder return is...
NasdaqGS:BBSI
NasdaqGS:BBSIProfessional Services

3 U.S. HR Tech Stocks for Investors Watching Overtime Rule Changes

Overtime rules rarely grab headlines, yet a shift from a 40 hour to a 32 hour threshold could quietly reshape how employers think about every shift, schedule, and paycheck. That kind of change can ripple into demand for workforce software, compliance tools, and automation, which creates both openings and risks for investors. This article profiles 3 U.S. HR technology stocks tied to that policy story and examines where the potential pressure points and bright spots may sit for each one. The...
NYSE:CNX
NYSE:CNXOil and Gas

CNX Resources (CNX) Expands Real Time Radiation Monitoring In Pennsylvania

CNX Resources (NYSE:CNX) expanded its transparency collaboration with Pennsylvania regulators to include real-time radiation monitoring at its well pads and water sites. The expanded program adds continuous radiation tracking and public disclosure for waste transportation tied to CNX-operated facilities in the state. State authorities are involved in reviewing and sharing the monitoring data, which is intended to be accessible to nearby communities. CNX's move into real-time radiation...
NasdaqGS:OCFC
NasdaqGS:OCFCBanks

OceanFirst Financial (OCFC) Stock Looks Fully Priced As Its 40% Run Continues

OceanFirst Financial has delivered a solid 40.4% share price gain over the past three years, which naturally raises the question of whether its current valuation is still aligned with the earnings power of the business. For anyone watching regional banks, the issue now is how much of that performance is already reflected in today’s price. The 40.4% total return over three years puts real weight on the question of whether OceanFirst Financial’s earnings profile can continue to support the...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Zscaler (ZS) Following Agentic SOC Launch Looks Undervalued But Margin Pressure Clouds The View

How Zscaler’s Agentic SOC shifts the AI security story for investors Zscaler (ZS) has pushed deeper into AI security with its new Agentic SOC platform, which uses partner models from Anthropic and OpenAI to automate threat detection and response across customer environments. The launch leans on Zscaler telemetry, a large decoy mesh network and integrated zero trust controls to identify attacks earlier and contain them at machine speed, while still plugging into existing third-party security...
NYSE:LMND
NYSE:LMNDInsurance

Lemonade (LMND) Expands In Kentucky, Is The Stock Fully Valued?

Lemonade expands renters coverage and steps onto the conference stage Lemonade (LMND) just switched on renters insurance in Kentucky, widening its U.S. footprint as the insurer also prepares to showcase its model at the FT Partners FinTech Conference on September 15, 2026. Recent moves like the Kentucky launch and the upcoming FT Partners appearance come against a weaker share price backdrop, with Lemonade’s stock down 11.77% on a 30 day share price return and 38.01% on a year to date share...
NYSE:GFR
NYSE:GFROil and Gas

3 Oil Stocks Retail Investors May Revisit As Crude Prices Reset Energy Profits

Oil has suddenly become the main character again. With Brent crude up 72% YTD and shipping routes in the Middle East under threat, the shockwaves are hitting everything from fuel costs to inflation expectations. That kind of stress can punish some assets while giving others fresh momentum. This article explains how that story links to three individual energy stocks exposed to these headlines, and why each one may merit a closer look now. The stocks covered below are only a small sample of the...
NasdaqGS:COCO
NasdaqGS:COCOBeverage

What Is Drawing Fresh Attention To Vita Coco Company (COCO)?

Vita Coco Company (COCO) has drawn fresh attention after recent trading left the stock down about 12% over the past month and roughly 33% lower over the past 3 months. Despite that recent sell-off, Vita Coco Company's 1-year total shareholder return of 40.5% and 3-year total shareholder return of about 2.1x suggest long-term holders have still seen strong gains, even as the 90-day share price return has faded 32.7% and near-term momentum has cooled. Scan how Vita Coco Company's pullback...
NasdaqGS:PPC
NasdaqGS:PPCFood

Pilgrim's Pride (PPC) Expands In U.K. Ready Meals As Undervalued Narrative Holds

Pilgrim's Pride (PPC) is in focus after Pilgrim’s Europe agreed to produce Asian-inspired frozen ready meals for Associated British Foods’ Patak’s and Blue Dragon brands in a licensing partnership targeting the U.K. market. Against this partnership backdrop, Pilgrim's Pride is trading at US$29.85, with the share price up 12.09% over the past 90 days but down 25.13% year to date. Long term total shareholder return over three and five years remains positive at 54.48% and 23.64% respectively,...
NYSE:PCG
NYSE:PCGElectric Utilities

Did Community Microgrids Just Shift PG&E (PCG) Stock Narrative?

PG&E Corporation recently declared a third quarter 2026 regular cash dividend of US$0.05 per share, while Pacific Gas and Electric Company advanced more than US$73 million of community microgrid investments across Northern and Central California after selecting six new projects and signing grant agreements for earlier awards. The fresh wave of community microgrids, including the Pescadero project designed to run most of the town for at least 24 hours on local solar and batteries, highlights...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Apple (AAPL) Stock Could Look 31% Overvalued On New Health Device Launches

Apple has delivered a powerful run over the past several years. With the stock now around US$336, the real question for you is whether that price is properly supported by the cash the business can generate over time. Apple has returned 134.6% over the past 5 years, which puts a lot of emphasis on whether the underlying cash flows have kept pace with that kind of share price rise. Fresh product launches such as Apple Watch Series 12, Ultra 4 and AirPods 5, along with ongoing investment in...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian (RIVN) Stock May Be Fully Priced Following CFO Exit

Rivian Automotive has seen its share price move through sharp swings in recent years, and that leaves a clear question for investors who care about the numbers: Is the current US$14.99 price tag meaningfully supported by the sales Rivian is generating today and is expected to produce over time? Over the past 3 years the stock has fallen 27.2%, which puts the focus squarely on whether the revenue it is posting can carry the current valuation. Rivian's role as an early adopter of Stratasys'...